Para brindar el contenido más relevante a los lectores de HealthCare Business News, le pedimos que comparta un poco de información sobre quién es usted (tarda dos segundos y listo).
Registro
Medtronic's medical supplies unit may go to Cardinal Health for $6 billion
An unnamed source told the news agency that these assets had earnings before interest, taxes, depreciation and amortization of around $500 million and advised that they would go for “eight to 10 times that amount.”
When the Covidien acquisition was announced, Medtronic CEO Omar Ishrak told Bloomberg that the reasons for the deal were “strategic and operational alignment,” adding that it “will drive better value for patients and customers around the world.”
Ishrak noted at the time that, "this acquisition will allow Medtronic to reach more patients, in more ways and in more places," adding that, “our expertise and portfolio of services will allow us to serve our customers more efficiently and better address the demands of the current health care marketplace."
Even when the deal happened, however, it seemed that the “commodity” medical supply business was an unlikely fit with much of the higher-technology Medtronic business, such as pacemakers and neurostimulators.